Cochlear Limited COH.ASX

Cochlear Ltd is a medical company that develops devices to help people with hearing impairments with an additional focus on diagnostics. It was founded in 1981 and has its headquarters in Sydney. Cochlear invests as much as 160m AUD every year into the research of new products to help people with hearing difficulties.

As the name of the company suggests, one of its main products is the cochlear implant. One of the most popular devices that it has developed is the Nucleus sound processor, which was the first implant of its kind to be approved by the FDA. In September 2019, Cochlear, in collaboration with the company GN Hearing, became the world’s first supporter of direct Android streaming to hearing devices using Bluetooth Low Energy.

In 2011, Cochlear was rewarded the title of being one of the world’s most innovative companies by Forbes. Cochlear has supplied over 600,000 implantable devices since its launch of the first cochlear implant system almost forty years ago. Cochlear Ltd has seen significant growth since it was first floated on the ASX under the ticker COH.

If you wish to keep track of news and changes regarding the price movements of Cochlear Ltd, then add COH to your eToro watchlist to stay updated.